QualityStocksNewsBreaks Archives - Page 1216 of 1453

TuesdayJan 08, 2019 10:29 am

QualityStocksNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Engages Brown and Caldwell as Primary Environmental and Permitting Consultant for Iron Creek

Vertically integrated North American pure-play cobalt company First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) this morning announced its engagement of Brown and Caldwell as its primary environmental and permitting consultant for its Iron Creek Project in Idaho, where the firm will provide guidance on permitting and develop an environmental baseline study strategy. According to the update, First Cobalt’s engagement of Brown and Caldwell is due to its strong reputation as a leading environmental consulting, engineering, design, and construction firm with over 70 years of experience and more than 55 offices across the U.S. and Canada. “First Cobalt's strategy…

TuesdayJan 08, 2019 10:24 am

QualityStocksNewsBreaks – Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Announces Launch of SmartSuite® Energy Management Solution

Smart energy technology company Kontrol Energy (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) this morning announced the launch of a new IOT energy management hardware and software solution for the global commercial, multi-residential and hospitality real estate markets. Per the update, the Kontrol SmartSuite® thermostat leverages assets attained through the company’s 2016 acquisition of LOG-1 EMS, an energy management thermostat with more than 20,000 units deployed across Canada. Capabilities and features of the new SmartSuite® device include real-time energy management and conversation, rich data analytics, smart learning algorithms, multiple user interfaces, Bluetooth connection, integration options with window and door sensors and…

TuesdayJan 08, 2019 10:08 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Enters Technology-Focused Cannabis Vertical via Investment in Headset, Inc.; Secures $80M Financial Development for PharmHouse

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced its completion of an equity investment in Headset, Inc., a data and analytics service provider for the cannabis industry. Representing its first entry into a technology-focused cannabis vertical, Canopy Rivers subscribed for CAD $4,084,500 of Series A Preferred Shares in Headset. In addition, the company recently announced that its 49 percent-owned joint venture PharmHouse Inc. has entered into a syndicated credit facility with the Bank of Montreal (“BMO”), as agent and lead lender, and with Canadian Imperial Bank of Commerce and Concentra Bank as lenders. According to the update, under the…

TuesdayJan 08, 2019 9:29 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) to Present at Biotech Showcase Conference

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced that it will be presenting at the Biotech Showcase at the Hilton San Francisco Union Square in San Francisco, California on January 9, 2019 at 10:30 AM PT. An update on the company’s clinical development programs and objectives for leronlimab (PRO 140) will be co-presented by president and CEO Nader Pourhassan, Ph.D. and chief medical officer and vice chairman Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P. The presentation will provide insights regarding the company’s plans for 2019, including details on its first BLA submission of PRO 140 anticipated to occur during…

TuesdayJan 08, 2019 8:30 am

QualityStocksNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Updates Shareholders with 2018 Milestones and 2019 Strategic Goals

Canada-based exploration company Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) recently provided a shareholder update detailing the company’s 2018 milestones and growth initiatives, as well as strategic goals for 2019. According to the update, the company’s primary objectives for 2018 included exploration of its Cyclops Nickel-Cobalt Project, located in Jayapura Province, Indonesia. The company conducted extensive consultation with local stakeholders and regional government officials, resulting in overwhelming support for advancement of the Cyclops Project. In addition, in November of 2018, the company announced strong results from a mini-bulk sample at the project, bolstering Pacific Rim’s long-held views that…

MondayJan 07, 2019 2:51 pm

QualityStocksNewsBreaks – Medical Cannabis Payment Solutions (REFG) Ideally Positioned as Federal Hemp Laws Transform

With the recent passing of the Agriculture Improvement Act of 2018 in both the House of Representatives and the Senate legalizing of the production of hemp, Medical Cannabis Payment Solutions (OTC: REFG) is positioned at the forefront of the booming industry. A recent article discussing the company reads, “The company has been willing to take risks early on in anticipation of an emerging market and legalization in the United States. In doing so, REFG has grown a loyal customer base, providing a much-needed service in an industry that others were not willing to enter. … Now, as legislation such as…

MondayJan 07, 2019 2:19 pm

QualityStocksNewsBreaks – Existing Infrastructure at QMC Quantum Minerals Corp.’s (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Irgon Mine Project to Drive Speedy Development

Exploration at QMC Quantum Minerals’ (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Irgon Lithium Mine Project commenced almost half a century ago, leaving existing infrastructure for the company to utilize. A recent article discussing the company reads, “In 2019, QMC plans to increase the rate of development and the subsequent production of lithium from pegmatite dikes. The company will benefit from the infrastructure that is already in place, which could ensure rapid development. … The infrastructure existing at the mining site from the past includes a previously excavated 241-foot-deep, three-compartment shaft and 1,120 feet of underground drifting off the 200-foot level.…

MondayJan 07, 2019 11:34 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Invests in TorusMed Inc. for Lab-Based Development of CBD Cell Cultures

Technology and investment company SinglePoint (OTCQB: SING) this morning announced its investment in TorusMed Inc. to develop cannabidiol (“CBD”) cell cultures from industrial hemp. According to the update, the ultimate goal of the project is the development of pharmaceutical grade CBD that is cultivated in lab settings, potentially changing the way industrial hemp and CBD are manufactured, reducing time, cost and resources while increasing consistency, safety and scalability. The project’s specific aim is to develop optimal protocols for mass CBD production from cell cultures of industrial hemp, which offers several advantages as compared to open-field farm cultivation including, but not…

MondayJan 07, 2019 10:39 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Eagerly-Anticipated Commercial Launch of Biopharmaceuticals Contract Services Business

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced the commercial launch of its Biopharmaceuticals Contract Services Business. The eagerly-anticipated launch follows PBIO’s December 2017 acquisition of the assets of BaroFold, Inc., including patents, equipment, and other intellectual property relating to its unique, high pressure-based protein disaggregation and refolding platform. PBIO expects the technology platform to offer substantial improvement in the quality and costs of manufacturing protein therapeutics. “We are excited to announce the launch of our Biopharmaceutical Contract Services Business…

MondayJan 07, 2019 9:57 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Names Richard G. Pestell, M.D., Ph.D. as Board Vice Chairman, Expanding Leadership Role in Advancement of Company Initiatives

Biotechnology company CytoDyn (OTCQB: CYDY) today announced the election of its Chief Medical Officer and Director Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P. to the additional position of vice chairman of the board of directors. In this added role Pestell, an internationally renowned clinician and cancer researcher and defining force in CCR5 antagonist research, will advance and accelerate CYDY’s initiatives in seeking non-dilutive licensing opportunities in cancer and immunology. “We are honored to have Dr. Pestell serve as our Vice Chairman,” CytoDyn President and Chief Executive Officer Nader Pourhassan stated in the news release. “He is a world renowned…

Site Search

Company Search

Category: QualityStocksNewsBreaks